Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers.
Saved in:
| Title: | Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers. |
|---|---|
| Authors: | Fernández Montes, Ana1 (AUTHOR) afm1003@hotmail.com, Martínez Lago, Nieves2 (AUTHOR), Covela Rúa, Marta3 (AUTHOR), de la Cámara Gómez, Juan4 (AUTHOR), González Villaroel, Paula5 (AUTHOR), Méndez Méndez, José Carlos6 (AUTHOR), Jorge Fernández, Mónica4 (AUTHOR), Salgado Fernández, Mercedes1 (AUTHOR), Reboredo López, Margarita2 (AUTHOR), Quintero Aldana, Guillermo3 (AUTHOR), Luz Pellón Augusto, María4 (AUTHOR), Graña Suárez, Begoña2 (AUTHOR), García Gómez, Jesús1 (AUTHOR) |
| Source: | Cancer Medicine. Mar2019, Vol. 8 Issue 3, p882-889. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.1903 |
